MY185134A - 6-substituted phenoxychroman carboxylic acis derivatives - Google Patents
6-substituted phenoxychroman carboxylic acis derivativesInfo
- Publication number
- MY185134A MY185134A MYPI2014001094A MYPI2014001094A MY185134A MY 185134 A MY185134 A MY 185134A MY PI2014001094 A MYPI2014001094 A MY PI2014001094A MY PI2014001094 A MYPI2014001094 A MY PI2014001094A MY 185134 A MY185134 A MY 185134A
- Authority
- MY
- Malaysia
- Prior art keywords
- derivatives
- substituted
- acis
- phenoxychroman carboxylic
- carboxylic acis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7561508P | 2008-06-25 | 2008-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY185134A true MY185134A (en) | 2021-04-30 |
Family
ID=40996727
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2010006174A MY161425A (en) | 2008-06-25 | 2009-06-24 | 6-substituted phenoxychroman carboxylic acid derivatives |
MYPI2014001094A MY185134A (en) | 2008-06-25 | 2009-06-24 | 6-substituted phenoxychroman carboxylic acis derivatives |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2010006174A MY161425A (en) | 2008-06-25 | 2009-06-24 | 6-substituted phenoxychroman carboxylic acid derivatives |
Country Status (33)
Country | Link |
---|---|
US (4) | US8569522B2 (ru) |
EP (3) | EP2826774B1 (ru) |
JP (2) | JP5753780B2 (ru) |
KR (1) | KR101728175B1 (ru) |
CN (2) | CN103450138B (ru) |
AR (1) | AR072301A1 (ru) |
AU (1) | AU2009262274B2 (ru) |
BR (1) | BRPI0915513B8 (ru) |
CA (1) | CA2729217C (ru) |
CL (1) | CL2010001528A1 (ru) |
CO (1) | CO6362002A2 (ru) |
CR (1) | CR20110037A (ru) |
CY (1) | CY1115650T1 (ru) |
DK (1) | DK2307397T3 (ru) |
ES (2) | ES2582161T3 (ru) |
HK (1) | HK1155735A1 (ru) |
HR (1) | HRP20140988T1 (ru) |
IL (2) | IL210198A (ru) |
MX (1) | MX2011000173A (ru) |
MY (2) | MY161425A (ru) |
NZ (1) | NZ590437A (ru) |
PH (1) | PH12014500079A1 (ru) |
PL (1) | PL2307397T3 (ru) |
PT (1) | PT2307397E (ru) |
RS (1) | RS53665B1 (ru) |
RU (1) | RU2507200C2 (ru) |
SG (2) | SG2014013528A (ru) |
SI (1) | SI2307397T1 (ru) |
TW (2) | TWI436990B (ru) |
UA (1) | UA104867C2 (ru) |
UY (1) | UY31938A (ru) |
WO (1) | WO2009158426A1 (ru) |
ZA (1) | ZA201100604B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2507200C2 (ru) | 2008-06-25 | 2014-02-20 | Эррэй Биофарма Инк. | Производные феноксихроманкарбоновой кислоты, замещенные в 6-ом положении |
WO2010075200A1 (en) * | 2008-12-22 | 2010-07-01 | Array Biopharma Inc. | 7-phenoxychroman carboxylic acid derivatives |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
TWI654180B (zh) | 2012-06-29 | 2019-03-21 | 美商艾佛艾姆希公司 | 殺真菌之雜環羧醯胺 |
TW201507722A (zh) * | 2013-04-30 | 2015-03-01 | Bayer Cropscience Ag | 做為殺線蟲劑及殺體內寄生蟲劑的n-(2-鹵素-2-苯乙基)-羧醯胺類 |
WO2015126750A1 (en) | 2014-02-19 | 2015-08-27 | Array Biopharma Inc. | BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO TREATMENT WITH A CRTh2 INHIBITOR |
CN111057003A (zh) * | 2019-12-06 | 2020-04-24 | 广安凯特制药有限公司 | 一种立他司特中间体5,7-二氯-1,2,3,4-四氢异喹啉的合成方法 |
SE2151519A1 (en) * | 2021-12-10 | 2023-06-11 | Amidea Sweden Ab | 2-(2,5-dimethoxyphenyl)ethanamine and uses thereof |
CN114181039A (zh) * | 2021-12-23 | 2022-03-15 | 凯美克(上海)医药科技有限公司 | 一种4,4-二苯基-3-丁烯-1-醇的合成方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059609A (en) | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
US5006550A (en) * | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
US5952326A (en) | 1997-12-10 | 1999-09-14 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases |
DE19850131A1 (de) * | 1998-10-30 | 2000-05-04 | Merck Patent Gmbh | Chromenon- und Chromanonderivate |
DK1178984T3 (da) | 1999-05-21 | 2003-06-10 | Pfizer Prod Inc | 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater |
KR100884709B1 (ko) * | 2000-09-14 | 2009-02-19 | 미쓰비시 타나베 파마 코퍼레이션 | 신규한 아미드 유도체의 광학 활성체 및 그의 의약적 용도 |
WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
BR0317591A (pt) | 2002-12-20 | 2005-11-22 | Amgen Inc | Composto, sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, métodos para tratar uma doença ou condição, para modular a função de crth2 e/ou um ou mais outros receptores de pgd2 em uma célula e para modular crth2 e/ou um ou mais outros receptores de pgd2 |
CA2599352A1 (en) * | 2005-02-25 | 2006-09-08 | Eli Lilly And Company | Novel lipoxygenase inhibitors |
GB0611781D0 (en) * | 2006-06-14 | 2006-07-26 | Argenta Discovery Ltd | 2-Oxo-2H-Chromene Compounds |
AU2007286829B2 (en) | 2006-08-21 | 2013-05-02 | Array Biopharma, Inc. | 4-substituted phenoxyphenylacetic acid derivatives |
CA2667249A1 (en) * | 2006-10-31 | 2008-05-08 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
US7960567B2 (en) * | 2007-05-02 | 2011-06-14 | Amgen Inc. | Compounds and methods useful for treating asthma and allergic inflammation |
US8362056B2 (en) | 2007-11-05 | 2013-01-29 | Array Biopharma Inc. | 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives |
RU2507200C2 (ru) | 2008-06-25 | 2014-02-20 | Эррэй Биофарма Инк. | Производные феноксихроманкарбоновой кислоты, замещенные в 6-ом положении |
WO2010075200A1 (en) * | 2008-12-22 | 2010-07-01 | Array Biopharma Inc. | 7-phenoxychroman carboxylic acid derivatives |
-
2009
- 2009-06-24 RU RU2011102595/04A patent/RU2507200C2/ru active
- 2009-06-24 MY MYPI2010006174A patent/MY161425A/en unknown
- 2009-06-24 EP EP13195749.0A patent/EP2826774B1/en active Active
- 2009-06-24 MX MX2011000173A patent/MX2011000173A/es active IP Right Grant
- 2009-06-24 UA UAA201100801A patent/UA104867C2/ru unknown
- 2009-06-24 EP EP09770959.6A patent/EP2307397B1/en active Active
- 2009-06-24 NZ NZ590437A patent/NZ590437A/en not_active IP Right Cessation
- 2009-06-24 MY MYPI2014001094A patent/MY185134A/en unknown
- 2009-06-24 SG SG2014013528A patent/SG2014013528A/en unknown
- 2009-06-24 CN CN201310354758.0A patent/CN103450138B/zh not_active Expired - Fee Related
- 2009-06-24 CA CA2729217A patent/CA2729217C/en not_active Expired - Fee Related
- 2009-06-24 SG SG2014013544A patent/SG2014013544A/en unknown
- 2009-06-24 SI SI200931031T patent/SI2307397T1/sl unknown
- 2009-06-24 ES ES13195749.0T patent/ES2582161T3/es active Active
- 2009-06-24 EP EP16170994.4A patent/EP3144303B1/en active Active
- 2009-06-24 ES ES09770959.6T patent/ES2524314T3/es active Active
- 2009-06-24 PL PL09770959T patent/PL2307397T3/pl unknown
- 2009-06-24 BR BRPI0915513A patent/BRPI0915513B8/pt not_active IP Right Cessation
- 2009-06-24 RS RS20140627A patent/RS53665B1/en unknown
- 2009-06-24 US US13/001,201 patent/US8569522B2/en not_active Expired - Fee Related
- 2009-06-24 WO PCT/US2009/048499 patent/WO2009158426A1/en active Application Filing
- 2009-06-24 AU AU2009262274A patent/AU2009262274B2/en not_active Ceased
- 2009-06-24 UY UY0001031938A patent/UY31938A/es not_active Application Discontinuation
- 2009-06-24 JP JP2011516614A patent/JP5753780B2/ja not_active Expired - Fee Related
- 2009-06-24 CN CN2009801332711A patent/CN102131794B/zh not_active Expired - Fee Related
- 2009-06-24 DK DK09770959.6T patent/DK2307397T3/da active
- 2009-06-24 PT PT97709596T patent/PT2307397E/pt unknown
- 2009-06-24 AR ARP090102331A patent/AR072301A1/es active IP Right Grant
- 2009-06-24 KR KR1020117001795A patent/KR101728175B1/ko active IP Right Grant
- 2009-06-25 TW TW098121432A patent/TWI436990B/zh not_active IP Right Cessation
- 2009-06-25 TW TW103112407A patent/TWI476186B/zh not_active IP Right Cessation
-
2010
- 2010-12-23 IL IL210198A patent/IL210198A/en active IP Right Grant
- 2010-12-23 CL CL2010001528A patent/CL2010001528A1/es unknown
-
2011
- 2011-01-21 CR CR20110037A patent/CR20110037A/es unknown
- 2011-01-24 ZA ZA2011/00604A patent/ZA201100604B/en unknown
- 2011-01-28 CO CO11010027A patent/CO6362002A2/es active IP Right Grant
- 2011-09-21 HK HK11109937.4A patent/HK1155735A1/xx not_active IP Right Cessation
-
2013
- 2013-08-29 US US14/013,898 patent/US8716498B2/en not_active Expired - Fee Related
-
2014
- 2014-01-08 PH PH12014500079A patent/PH12014500079A1/en unknown
- 2014-03-27 JP JP2014065161A patent/JP2014122241A/ja not_active Withdrawn
- 2014-03-31 US US14/231,356 patent/US9096567B2/en not_active Expired - Fee Related
- 2014-10-15 HR HRP20140988AT patent/HRP20140988T1/hr unknown
- 2014-10-21 CY CY20141100859T patent/CY1115650T1/el unknown
-
2015
- 2015-05-04 US US14/702,947 patent/US9556139B2/en active Active
- 2015-09-21 IL IL241754A patent/IL241754A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY185134A (en) | 6-substituted phenoxychroman carboxylic acis derivatives | |
UA96459C2 (ru) | 4-замещенные производные феноксифенилуксусной кислоты | |
MY152062A (en) | Indole derivatives as crth2 receptor antagonists | |
UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
MX2011013034A (es) | 1-(piperidin-4-yl)-pirazol derivados como moduladores de gpr 119. | |
MY150518A (en) | Substituted gamma lactams as therapeutic agents | |
MA32272B1 (fr) | Inhibiteurs de raf de pyrazole [3,4-b]pyridine | |
WO2010106457A3 (en) | 3-oxa-7-azabicyclo[3.3.1]nonanes | |
UA105911C2 (ru) | Сульфонамидные производные | |
PH12012502568A1 (en) | Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts | |
IN2012DN02081A (ru) | ||
MX2012000414A (es) | Derivados piridin-4-ilo. | |
UA106367C2 (ru) | Производные азадиспиро[3.0.4.1]декана и их применение | |
MY147649A (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
MX2012004264A (es) | Derivados de sulfoxidos para el tratamiento de tumores. | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
UA106200C2 (ru) | Замещенные производные оксиндола и их применение для лечения заболеваний, зависимых от вазопресина | |
UA109793C2 (ru) | Арилсульфонамиды для лечения заболеваний центральной нервной системы (цнс) | |
MX2011013324A (es) | Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor. | |
ZA200705490B (en) | Substituted benzimidazoles for treatment of histomoniasis | |
MY150436A (en) | 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof | |
MX2009011214A (es) | Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. |